Authors: Danes, I Arnau, JM

Citation: I. Danes et Jm. Arnau, Safety of quinolones administration in children?, MED CLIN, 117(17), 2001, pp. 676-677

Authors: Cobos, N Danes, I Gartner, S Gonzalez, M Linan, S Arnau, JM

Citation: N. Cobos et al., DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres, EUR J PED, 159(3), 2000, pp. 176-181

Authors: Bonet, S Agusti, A Arnau, JM Vidal, X Diogene, E Galve, E Laporte, JR

Citation: S. Bonet et al., beta-adrenergic blocking agents in heart failure - Benefits of vasodilating and nonvasodilating agents according to patients' characteristics: A meta-analyis of clinical trials, ARCH IN MED, 160(5), 2000, pp. 621-627

Authors: Bonet, S Agusti, A Arnau, JM Vidal, X Diogene, E Galve, E Laporte, JR

Citation: S. Bonet et al., beta-blockers in congestive heart failure: Is there a difference between classes? In reply, ARCH IN MED, 160(19), 2000, pp. 3005-3006

Authors: Vallano, A Aguilera, C Arnau, JM Banos, JE Laporte, JR

Citation: A. Vallano et al., Management of postoperative pain in abdominal surgery in Spain. A multicentre drug utilization study, BR J CL PH, 47(6), 1999, pp. 667-673